1 Min Read
“I remember when we decided the internet was going to cure everything, and it didn’t…it came with a certain set of problems,” said Mark Bagnall, CEO of Phenomix Sciences. GLP-1s are having a similar moment, he says. GLP-1s have been transformative for many; by 2025, more than 30 million Americans were taking them for weight… The post Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity market appeared first on Drug Discovery and Development.
Work & Theory on April 9, 2026
Uncategorized